the results of the in vitro and in vivo standard test procedures demonstrate that actinomycin d is useful for the treatment of hyper proliferative vascular disease. specifically actinomycin d is useful for the inhibition of smooth muscle cell hyperplasia, restenosis and vascular occlusion in a mammal, particularly occlusions following a mechanically mediated vascular trauma or injury.